Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”. (Q51818581)

13 April 2018

title

Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”. (English)

1 reference

13 April 2018

author name string

Amy C Sturm

series ordinal

1

1 reference

13 April 2018

Kandamurugu Manickam

series ordinal

2

1 reference

13 April 2018

publication date

1 June 2012

1 reference

13 April 2018

Journal of Genetic Counseling

published in

1 reference

13 April 2018

volume

21

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

page(s)

402-412

1 reference

13 April 2018

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Effect of direct-to-consumer genomewide profiling to assess disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Family history of cancer and risk of esophageal and gastric cancers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Evaluating the utility of personal genomic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Limitations of direct-to-consumer advertising for clinical genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Disclosure of APOE genotype for risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Genotype announcement to Japanese smokers who attended a health checkup examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Putting science over supposition in the arena of personalized genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

The need for medical education reform: genomics and the changing nature of health information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

An agenda for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Genetic evaluation for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Expanding the definition of a positive family history for early-onset coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Delivery of genomic medicine for common chronic adult diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Multigenic condition risk assessment in direct-to-consumer genomic services

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Evaluation of risk prediction updates from commercial genome-wide scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9489-7

Genetic risk estimation in the Coriell Personalized Medicine Collaborative

21 January 2018

1 reference

12 December 2020

Cancer risk associated with pulp and paper mills: a review of occupational and community epidemiology.

1 reference

12 December 2020

Genetic risk information for common diseases may indeed be already useful for prevention and early detection

1 reference

12 December 2020

HFE-associated hereditary hemochromatosis

1 reference

12 December 2020

The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors

1 reference

12 December 2020

Heredity and risk of cancer of the esophagus and gastric cardia

1 reference

12 December 2020

Marketing Genetic Tests: Empowerment or Snake Oil?

1 reference

12 December 2020

Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change.

1 reference

12 December 2020

Personal genomics: information can be harmful

1 reference

12 December 2020

A pilot study on genotype announcement to induce smoking cessation by Japanese smokers.

1 reference

12 December 2020

Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income

1 reference

12 December 2020

The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing

1 reference

12 December 2020

Educating health-care professionals about genetics and genomics

1 reference

12 December 2020

10.1007/S10897-012-9489-7

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018